MedTrace Logo

EEG Biofeedback in the Treatment of Chronic Treatment-Resistant PTSD

NCT01259921 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2019-08-15

No results posted yet for this study

Summary

The purpose of this study is to determine whether neurofeedback (NF) training can significantly reduce the symptoms of Posttraumatic Stress Disorder (PTSD) in individuals with significant affect dysregulation and chronic, treatment-resistant PTSD. The primary aims of this study include:

1. To examine whether NF has the potential to significantly reduce symptoms of PTSD.
2. To examine whether NF training can specifically target the area of affect regulation.
3. To examine the mechanism of NF through elucidating the relationship between affect regulation and PTSD symptom change.

Conditions

Interventions

BEHAVIORAL

neurofeedback

Operant conditioning of the EEG provided by computer reinforcement.

Sponsors & Collaborators

  • Justice Resource Institute

    lead OTHER

Principal Investigators

  • Bessel van der Kolk, M.D. · Justice Resource Institute

  • Mark Gapen, Ph.D. · Justice Resource Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01259921 on ClinicalTrials.gov